In a sit-down interview at the annual J.P. Morgan Healthcare conference, Allen talked about a tool built by a company backed by General Catalyst and Andreessen Horowitz.
The randomized trial is the first to assess fecal microbiota transplantation for treating diabetic gastroenteropathy, highlighting its safety and efficacy.
Patient flow automation startup Qventus closed a $105 million Series D financing round. The company’s technology is used by more than 115 hospitals and health…
SAN FRANCISCO — In 2022, Advocate Aurora Health and Atrium Health came together to form the massive health system Advocate Health. | Under this program,…
Eli Lilly CEO said he believed the company could find “significant common cause” with the Trump administration, even if there were reasons for concern.
Capital One has been accused of ‘cheating’ customers out of $2 billion. A federal watchdog is seeking compensation for affected customers in its lawsuit, which…
A Lancet commission downplays BMI and calls for “preclinical” and “clinical” categories of obesity.
Why do some people develop severe flu symptoms? A Stanford Medicine study points the finger at an unsung portion of the antibodies our immune systems…
Wildfire smoke is about 10 times as toxic as the regular air pollution from the burning of fossil fuels, and there’s no safe level of…
The ‘Evolving Role of the Contact Center – More Than Just Customer Service’ panel session will address how AI is having a transformational impact on…
